P
Propanc Biopharma, Inc. (PPCB)
NCM – Real Time Price. Currency in USD
0.09
-0.00 (-3.83%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.09
-0.00 (-3.83%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $1.6M significantly exceeds cash reserves ($561.2K), raising financial stability concerns
Total current assets $7.7M exceed Total current liabilities $3.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-62.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.13 | 6.05 | 10 | |
| Quick ratio | 2.13 | 5.63 | 10 | |
| Debt to Equity | 0.16 | 0.30 | 9.0 | |
| Debt to Assets | 0.11 | 1.04 | 9.0 | |
| Interest coverage | -61.99 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -6K | -23K | -22K | -20K | -20K |
| Operating Income | -2M | -2M | -2M | -57M | -65M |
| Net Income | -3M | -3M | -2M | -59M | -66M |
| EBITDA | -2M | -2M | -2M | -57M | -65M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 36.1 | N/A | 48.15 | 7.8 |
| Y/Y | 999 | -618.61 | N/A | -4763.07 | 3.3 |
| 3y average | 999 | -1035.02 | N/A | 31.7 | 5.5 |
| 5y average | 999 | -615.79 | N/A | 21.56 | 5.5 |
| Weighted average score | 5.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |